Börse:
3,004€
-6,13%
Echtzeit-Aktienkurs Compugen Ltd
Bid:
2,950€
Ask:
3,059€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 179,79 Mio. EUR (59,85 Mio. x 3,004€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| KUV | 16,38 | 215,73 | - | 10,10 |
| KGV | - | - | - | - |
| Div. Rend. | - | - | - | - |
Echtzeit-Chart der Compugen Ltd Aktie
Börsenkurse Compugen Ltd
| Lang & Schwarz | 3,005€ | 3977 | 3,030€ | 3977 | 3,018€ | 0,23% |
| Euro Indikation | 2,950€ | 0 | 3,059€ | 0 | 3,004€ | -6,13% |
| Dollar Indikation | 3,360$ | 0 | 3,407$ | 0 | 3,384$ | -0,19% |
| Börse Stuttgart | 2,950€ | 0 | 3,059€ | 0 | 3,004€ | 1,40% |
Fundamentaldaten der Compugen Ltd Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 17,80 Mio. | -22,60 Mio. | -22,60 Mio. | -0,41 | 0,00% | - | 10,10 |
| 2017 | 0,00 Mio. | -37,07 Mio. | -37,07 Mio. | -0,72 | 0,00% | - | - |
| 2016 | 0,71 Mio. | -31,49 Mio. | -31,51 Mio. | -0,62 | 0,00% | - | 215,73 |
| 2015 | 9,28 Mio. | -19,77 Mio. | -20,16 Mio. | -0,40 | 0,00% | - | 16,38 |
| 2014 | 12,37 Mio. | -10,58 Mio. | -11,09 Mio. | -0,23 | 0,00% | - | 12,21 |
Profil der Compugen Ltd Aktie
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen